Sudarshan Pharma Financials
BSE: 543828
₹38.50
₹-0.99
(-2.51%)
As on 11-Sep-2026 14:07IST
Market cap
₹1,005 Cr
Revenue (TTM)
₹732 Cr
P/E Ratio
40
P/B Ratio
3.1
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
732.21
|
505.05
|
463.54
|
461.33
|
357.09
|
193.35
|
|
|
|
|
|
|
Total Income
|
740.94
|
507.57
|
466.15
|
462.45
|
357.56
|
193.73
|
|
|
|
|
|
|
Total Expenditure
|
676.04
|
465.13
|
440.73
|
446.64
|
346.18
|
186.19
|
|
|
|
|
|
|
EBITDA
|
56.17
|
39.92
|
22.81
|
14.69
|
10.92
|
7.16
|
|
|
|
|
|
|
Depreciation
|
4.31
|
2.22
|
1.24
|
0.91
|
0.87
|
0.74
|
|
|
|
|
|
|
EBIT
|
51.86
|
37.70
|
21.57
|
13.78
|
10.05
|
6.42
|
|
|
|
|
|
|
Interest
|
27.95
|
15.77
|
8.94
|
5.40
|
3.38
|
3.23
|
|
|
|
|
|
|
Other Income
|
8.73
|
2.52
|
2.61
|
1.12
|
0.46
|
0.38
|
|
|
|
|
|
|
Exceptional Items
|
--
|
-2.82
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
32.64
|
21.63
|
15.23
|
9.50
|
7.14
|
3.57
|
|
|
|
|
|
|
Provision for Tax
|
7.61
|
5.68
|
3.77
|
2.46
|
1.89
|
0.90
|
|
|
|
|
|
|
Profit after Tax
|
25.02
|
15.95
|
11.46
|
7.04
|
5.25
|
2.67
|
|
|
|
|
|
|
Minority Interest
|
0.10
|
0.00
|
--
|
--
|
0.00
|
0.00
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
25.12
|
15.96
|
11.46
|
7.04
|
5.25
|
2.67
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
155.10
|
131.48
|
111.71
|
100.97
|
29.78
|
22.51
|
|
|
|
|
|
|
Minority Interest
|
0.10
|
0.00
|
--
|
--
|
--
|
0.05
|
|
|
|
|
|
|
Non-Current Liabilities
|
29.31
|
11.23
|
10.93
|
13.03
|
5.12
|
5.48
|
|
|
|
|
|
|
Current Liabilities
|
456.12
|
259.69
|
160.49
|
118.48
|
102.62
|
71.22
|
|
|
|
|
|
|
Total Liabilities
|
641.75
|
402.41
|
283.13
|
232.48
|
137.52
|
99.26
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
107.56
|
67.56
|
45.91
|
33.86
|
7.94
|
11.62
|
|
|
|
|
|
|
Current Assets
|
490.27
|
334.85
|
237.22
|
198.62
|
129.58
|
87.64
|
|
|
|
|
|
|
Total Assets
|
641.75
|
402.41
|
283.13
|
232.48
|
137.52
|
99.26
|
|
|
|
|
|
|
Total Debt*
|
--
|
170.73
|
104.84
|
34.10
|
30.59
|
29.77
|
|
|
|
|
|
|
Net Current Assets
|
34.15
|
75.15
|
76.73
|
80.15
|
26.96
|
16.42
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
28.58
|
0.40
|
0.20
|
0.19
|
0.02
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
35.22
|
7.75
|
-28.79
|
-3.82
|
2.77
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-20.41
|
-7.23
|
-25.65
|
-1.46
|
-1.29
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-14.45
|
-12.10
|
65.93
|
4.26
|
-1.49
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
0.37
|
-11.58
|
11.48
|
-1.02
|
-0.01
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
1.04
|
0.66
|
0.48
|
0.29
|
0.54
|
0.28
|
|
|
|
|
|
|
Cash EPS (₹)
|
0.99
|
0.76
|
0.53
|
0.33
|
0.63
|
0.36
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
12.89
|
5.30
|
4.64
|
4.20
|
3.05
|
2.36
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
0.03
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
1.46
|
3.22
|
-11.96
|
-3.92
|
2.90
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
0.59
|
-1.64
|
-20.11
|
-8.45
|
-1.90
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
14.42
|
13.75
|
15.25
|
18.67
|
13.01
|
|
|
|
|
|
|
ROE (%)
|
17.03
|
13.33
|
10.77
|
10.76
|
20.08
|
11.87
|
|
|
|
|
|
|
ROA (%)
|
7.80
|
4.65
|
4.44
|
3.80
|
4.43
|
2.69
|
|
|
|
|
|
|
EBIT Margin (%)
|
7.08
|
7.46
|
4.65
|
2.99
|
2.81
|
3.32
|
|
|
|
|
|
|
Net Margin (%)
|
3.38
|
3.14
|
2.46
|
1.52
|
1.47
|
1.38
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
3.60
|
2.74
|
1.72
|
1.71
|
1.77
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
32.86
|
8.95
|
0.48
|
29.19
|
84.69
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
15.31
|
74.80
|
56.50
|
37.12
|
56.50
|
--
|
|
|
|
|
|
|
Net Profit Growth (%)
|
12.52
|
39.26
|
62.79
|
34.07
|
96.49
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
23.24
|
39.29
|
62.80
|
-45.68
|
92.34
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
14.28
|
10.63
|
239.12
|
32.29
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
40.00
|
46.06
|
1.56
|
19.08
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
3.06
|
5.76
|
1.60
|
1.33
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
0.54
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
19.84
|
21.33
|
11.14
|
9.91
|
3.52
|
5.05
|
|
|
|
|
|
|
Close Price (₹)
|
37.51
|
30.54
|
7.41
|
5.58
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
40.41
|
53.50
|
9.19
|
7.33
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
18.50
|
5.82
|
5.19
|
5.19
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
1,004.90
|
735.00
|
178.37
|
134.29
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.18
|
1.34
|
0.94
|
0.34
|
1.03
|
1.32
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
1.19
|
0.81
|
0.18
|
0.79
|
0.95
|
|
|
|
|
|
|
Current Ratio
|
1.07
|
1.29
|
1.48
|
1.68
|
1.26
|
1.23
|
|
|
|
|
|
|
Quick Ratio
|
0.60
|
0.75
|
0.94
|
1.05
|
0.81
|
0.89
|
|
|
|
|
|
|
Interest Coverage
|
2.17
|
2.37
|
2.70
|
2.76
|
3.11
|
2.11
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
31.87
|
31.71
|
26.44
|
17.67
|
20.58
|
31.24
|
|
|
|
|
|
|
Asset Turnover
|
2.28
|
1.47
|
1.80
|
2.49
|
3.02
|
1.95
|
|
|
|
|
|
|
Receivable days
|
--
|
102.16
|
80.34
|
61.31
|
68.42
|
114.01
|
|
|
|
|
|
|
Inventory Days
|
--
|
81.75
|
63.12
|
48.04
|
36.20
|
45.24
|
|
|
|
|
|
|
Payable days
|
--
|
62.07
|
64.12
|
70.18
|
64.25
|
90.88
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
121.83
|
79.33
|
39.17
|
40.37
|
68.37
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
